Free Trial

CNS Pharmaceuticals (CNSP) SEC Filings & 10K Form

CNS Pharmaceuticals logo
$1.30 -0.02 (-1.52%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.21 -0.09 (-6.92%)
As of 03/28/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent CNS Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/20/2025
4:17 PM
CNS Pharmaceuticals (Filer)
Form 424B5
03/20/2025
4:15 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:00 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
11:24 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:19 PM
CNS Pharmaceuticals (Filer)
Form DEFR14A
11/01/2024
8:00 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:15 PM
CNS Pharmaceuticals (Filer)
Form DEF 14A
10/24/2024
4:27 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
10:23 AM
CNS Pharmaceuticals (Filer)
Form 424B5
10/23/2024
7:02 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:24 PM
CNS Pharmaceuticals (Filer)
Form PRE 14A
09/12/2024
7:58 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:22 PM
CNS Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:30 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:11 PM
CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:53 PM
CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2024
11:15 PM
CNS Pharmaceuticals (Filer)
Form EFFECT
07/31/2024
11:32 AM
CNS Pharmaceuticals (Filer)
Form RW
07/30/2024
4:13 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:15 PM
CNS Pharmaceuticals (Filer)
Form 424B3
07/30/2024
6:00 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
7:30 AM
CNS Pharmaceuticals (Filer)
Form 424B5
07/26/2024
7:00 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
8:30 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
4:12 PM
CNS Pharmaceuticals (Filer)
Form S-1/A
07/12/2024
3:30 PM
CNS Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/11/2024
6:38 PM
CNS Pharmaceuticals (Filer)
Form 8-K/A
07/09/2024
10:25 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
8:49 AM
CNS Pharmaceuticals (Filer)
Form 424B5
07/03/2024
3:56 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
11:34 AM
CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
Form SC 13G
06/27/2024
9:00 AM
CNS Pharmaceuticals (Filer)
Form 424B5
06/26/2024
4:25 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
6:19 PM
CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
Form SC 13G
06/20/2024
4:00 PM
CNS Pharmaceuticals (Filer)
Form 8-K/A
06/17/2024
10:17 AM
CNS Pharmaceuticals (Filer)
Form 424B5
06/14/2024
4:25 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2024
11:15 PM
CNS Pharmaceuticals (Filer)
Form EFFECT
05/16/2024
9:56 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:00 PM
CNS Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
4:28 PM
CNS Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

05/07/2024
4:00 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
5:37 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
8:50 PM
Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:50 PM
Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:51 PM
CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:51 PM
CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:52 PM
CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:52 PM
CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:52 PM
CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:53 PM
CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
6:40 PM
CNS Pharmaceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CNSP) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners